Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 8

Effect of high-dose N-acetylcysteine on airway geometry, inflammation, and oxidative stress in COPD patients

Authors De Backer J, Vos W, van Holsbeke C , Vinchurkar S, Claes R, Parizel P, De Backer W

Received 1 June 2013

Accepted for publication 13 August 2013

Published 22 November 2013 Volume 2013:8 Pages 569—579


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Jan De Backer,1 Wim Vos,1 Cedric Van Holsbeke,1 Samir Vinchurkar,1 Rita Claes,2 Paul M Parizel,3 Wilfried De Backer2

1FluidDA nv, Kontich, Belgium; 2Department Respiratory Medicine, University Hospital, Antwerp, Belgium; 3Department Radiology, University Hospital, Antwerp, Belgium

Background: Previous studies have demonstrated the potential beneficial effect of N-acetylcysteine (NAC) in chronic obstructive pulmonary disease (COPD). However, the required dose and responder phenotype remain unclear. The current study investigated the effect of high-dose NAC on airway geometry, inflammation, and oxidative stress in COPD patients. Novel functional respiratory imaging methods combining multislice computed tomography images and computer-based flow simulations were used with high sensitivity for detecting changes induced by the therapy.
Methods: Twelve patients with Global Initiative for Chronic Obstructive Lung Disease stage II COPD were randomized to receive NAC 1800 mg or placebo daily for 3 months and were then crossed over to the alternative treatment for a further 3 months.
Results: Significant correlations were found between image-based resistance values and glutathione levels after treatment with NAC (P = 0.011) and glutathione peroxidase at baseline (P = 0.036). Image-based resistance values appeared to be a good predictor for glutathione peroxidase levels after NAC (P = 0.02), changes in glutathione peroxidase levels (P = 0.035), and reduction in lobar functional residual capacity levels (P = 0.00084). In the limited set of responders to NAC therapy, the changes in airway resistance were in the same order as changes induced by budesonide/formoterol.
Conclusion: A combination of glutathione, glutathione peroxidase, and imaging parameters could potentially be used to phenotype COPD patients who would benefit from addition of NAC to their current therapy. The findings of this small pilot study need to be confirmed in a larger pivotal trial.

functional respiratory imaging, computational fluid dynamics, computed tomography, chronic obstructive pulmonary disease, N-acetylcysteine

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.